Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Inflammation × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 16 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 10 Lung Neoplasms 8 Recurrence 5 Neoplasm Metastasis 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Infertility 3 Urinary Bladder Neoplasms 2 Sezary Syndrome 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Insulin Resistance 2 Infertility, Female 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Diabetes, Gestational 2 Carcinoma, Transitional Cell 2 Atypical Squamous Cells of the Cervix 2 Anovulation 2 Adenoma 2 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Ureteral Neoplasms 1

Interventions

Omeprazole 3 Exercise 3 salicylsalicylic acid 2 palbociclib 2 XENP 1595 2 Vitamin D 2 Tea 2 Tablets 2 Sufentanil 2 Resistance Training 2 Nutrition Assessment 2 Metformin 2 Ketorolac 2 Ibuprofen 2 Fish Oils 2 Etanercept 2 Colchicine 2 Ascorbic Acid 2 soybean oil, phospholipid emulsion 1 montelukast 1 microcrystalline cellulose 1 ginger extract 1 falcarinol 1 falcarindiol 1 epigallocatechin gallate 1 dolutegravir 1 dapagliflozin 1 Trimethoprim, Sulfamethoxazole Drug Combination 1 Sulindac 1 Spironolactone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02302326 2020-02-26

PI12/1984

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Completed

Inflammation, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡